Early Reduction of MRI Activity During 6 Months of Treatment With Cladribine Tablets for Highly Active Relapsing Multiple Sclerosis
暂无分享,去创建一个
F. Barkhof | L. Leocani | X. Montalban | P. Vermersch | K. Schmierer | A. Achiron | T. Derfuss | H. Wiendl | F. Sellebjerg | S. Hodgkinson | B. Keller | N. de Stefano | Andrew T. Chan | Sanjeev Roy | Alexandre Prat | A. Prat | Claire Mwape | A. Chan